{"gene":"ETF1","run_date":"2026-06-11T12:11:54","timeline":{"discoveries":[{"year":1992,"finding":"Human TB3-1 (ETF1) encodes a 47.8-kDa protein sharing 73% amino acid similarity with yeast omnipotent suppressor 45 (SUP45), suggesting a conserved role in translation termination/stop codon recognition in mammalian cells.","method":"cDNA cloning from T84 adenocarcinoma library, open reading frame analysis, sequence homology comparison","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — structural homology to a characterized yeast translation termination factor established by sequence analysis; no in vitro functional assay performed in this paper, but independently confirmed by chromosomal mapping study","pmids":["1537561"],"is_preprint":false},{"year":1992,"finding":"TB3-1 (ETF1) genomic sequences map to human chromosomes 5, 6, 7, and X; the gene is well conserved in higher vertebrates including mammals and chicken.","method":"Human-mouse somatic cell panel analysis, Southern blot of mammalian and chicken genomic DNA","journal":"Somatic cell and molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct chromosomal localization by somatic cell panel and Southern blot, two orthogonal methods, single lab","pmids":["1546371"],"is_preprint":false},{"year":2000,"finding":"The functional ETF1 gene resides on chromosome 5q31 at locus D5S500 (within the smallest commonly deleted segment in myelodysplastic syndromes/AML); three processed pseudogenes exist on chromosomes 6, 7, and X.","method":"Fluorescence in situ hybridization (FISH), microsatellite marker identification in intron 7","journal":"Cytogenetics and cell genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — FISH-based chromosomal localization, replicated and extended by a subsequent study (PMID:11996793)","pmids":["10773672"],"is_preprint":false},{"year":2002,"finding":"ETF1/eRF1 is a class-1 release factor that catalyses termination of protein synthesis at all three stop codons; the ETF1 promoter lacks a TATA box but contains an initiator element (Inr) and Sp1/Sp3 binding sites consistent with housekeeping gene regulation, with tissue-specific expression detected by RT-PCR.","method":"Primer extension, RNase protection mapping, DNase I hypersensitive site analysis, transient expression assays, in vivo/in vitro footprinting, real-time quantitative RT-PCR","journal":"Cancer genetics and cytogenetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods characterizing promoter elements and transcriptional regulation; functional role as release factor stated but relies on homology; single lab","pmids":["11996793"],"is_preprint":false},{"year":2003,"finding":"The ETF1 gene promoter contains a basal promoter (−210/+117) with an Inr element and Sp1/Sp3 binding sites (no TATA box), plus an upstream region with both positive and negative regulatory elements, consistent with constitutive but tissue-regulated expression.","method":"Primer extension, RNase protection, DNase I hypersensitivity, transient expression assays, in vivo and in vitro footprinting, quantitative RT-PCR in mouse tissues","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal promoter-analysis methods in one study; single lab","pmids":["14563555"],"is_preprint":false},{"year":2011,"finding":"TDP-43 binding to UG-repeated sequences near the 5' splice site of ETF1 pre-mRNA can act as either an activator or a suppressor of 5' splice-site recognition, depending on splice-site strength and additional splicing regulatory sequences.","method":"Splicing assays with artificial and natural substrates; UG-repeat mutagenesis; minigene reporters for BRCA1, ETF1, and RXRG","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct experimental manipulation of UG repeats in ETF1 pre-mRNA splicing substrates; single lab, single method type","pmids":["22100394"],"is_preprint":false},{"year":2019,"finding":"Knockdown of ETF1 in human HepG2 cells alters the stability of specific mRNAs, and this change in mRNA half-life is inversely associated with altered transcription rates, such that mRNA abundance is buffered—demonstrating that ETF1 participates in a gene-expression buffering mechanism linking mRNA decay to transcription.","method":"siRNA knockdown of ETF1, mRNA stability measurements, transcription rate assays","journal":"RNA biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct knockdown with both stability and transcription-rate readouts in human cells; single lab","pmids":["31116665"],"is_preprint":false},{"year":2020,"finding":"eRF1 (ETF1 protein) accumulates within nuclear envelope invaginations in C9orf72-HRE patient iPSC neurons and postmortem tissue; its cytoplasmic redistribution is driven by nucleocytoplasmic transport disruption caused by C9-HRE. Overexpression of eRF1 together with UPF1 shifts translation toward NMD-dependent mRNA degradation and ameliorates C9-HRE toxicity in vivo.","method":"Subcellular fractionation coupled with tandem mass spectrometry; iPSC neuron and postmortem tissue immunostaining; eRF1/UPF1 overexpression in Drosophila and zebrafish C9-HRE models","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — proteome-wide fractionation-MS identifies redistribution, orthogonal imaging confirms localization, in vivo rescue experiments confirm functional role; multiple methods across multiple model systems","pmids":["32059759"],"is_preprint":false},{"year":2023,"finding":"Upon arsenite-induced oxidative stress, eRF1 (ETF1) relocalizes to stress granules (SGs) coinciding with a dramatic increase in stop-codon readthrough rate and elevated translation reinitiation levels, suggesting eRF1 sequestration in SGs contributes to reduced translation termination fidelity under stress.","method":"Immunofluorescence localization of eRF1 and other translation factors to SGs; stop-codon readthrough reporter assays; translation reinitiation assays on uORF-containing and bicistronic mRNAs","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct imaging of eRF1 localization to SGs plus functional readthrough assays; single lab, mechanistic link is correlative","pmids":["36672194"],"is_preprint":false},{"year":2024,"finding":"ETF1 isoform 2 (33 amino acids shorter than canonical eRF1 isoform 1) retains the ability to interact with ribosomal subunits and pre-termination complexes and to interact with eRF3a, but shows decreased codon recognition and peptide release activities, exhibits UGA unipotency, and stimulates eRF3a GTPase activity significantly less than isoform 1; it suppresses stop-codon readthrough of uORFs and decreases translation efficiency of long coding sequences.","method":"Reconstituted mammalian in vitro translation system; ribosome-binding and pre-termination complex interaction assays; GTPase activity assay; stop-codon readthrough reporters; cell-free translation system","journal":"International journal of molecular sciences","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro translation system with direct functional assays (peptide release, codon recognition, GTPase stimulation, readthrough); multiple orthogonal biochemical methods; single lab","pmids":["39063238"],"is_preprint":false},{"year":2025,"finding":"Small-molecule photo-stereoprobes identified by phenotypic screening bind directly to ETF1 (eRF1) — confirmed by chemical proteomics and recombinant purified ETF1 — and modulate programmed ribosomal frameshifting essential for SARS-CoV-2 replication without causing ETF1 degradation, thereby suppressing replication of multiple viruses with non-canonical frameshifting mechanisms.","method":"Phenotypic screening of photoreactive small-molecule library; chemical proteomics (photoaffinity labeling); binding confirmation with recombinant purified ETF1; frameshifting reporter assays; viral replication assays","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — chemical proteomics plus recombinant protein binding and functional frameshifting assays; preprint, single lab","pmids":["40909472"],"is_preprint":true},{"year":2021,"finding":"The KDM3B-ETF1 fusion gene (arising from chromosomal rearrangement) targets the LMO2 locus via chromatin immunoprecipitation-confirmed binding, reduces LMO2 expression, and activates the WNT/β-catenin signaling pathway to promote breast cancer cell invasion and metastasis.","method":"Chromatin immunoprecipitation (ChIP), Western blot, cell counting kit-8, Transwell invasion assay, tumor xenograft in nude mice; KDM3B-ETF1 overexpression and knockdown","journal":"Cancer gene therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirms direct targeting of LMO2 by the fusion protein; multiple functional assays in vitro and in vivo; single lab; applies to fusion protein, not canonical ETF1 alone","pmids":["33828234"],"is_preprint":false}],"current_model":"ETF1 encodes eukaryotic release factor 1 (eRF1), a class-1 translation termination factor that recognizes all three stop codons, induces peptide release from the ribosome, and stimulates eRF3 GTPase activity; a shorter isoform 2 retains ribosome binding and eRF3 interaction but shows reduced catalytic activity and UGA-only codon recognition; under oxidative stress eRF1 relocalizes to stress granules coinciding with increased stop-codon readthrough, and in C9orf72-ALS/FTD neurons its cytoplasmic redistribution shifts the cell toward NMD-dependent mRNA degradation; small molecules that bind eRF1 modulate programmed ribosomal frameshifting to suppress viral replication, and a KDM3B-ETF1 fusion protein represses LMO2 via WNT/β-catenin signaling to promote breast cancer invasion."},"narrative":{"mechanistic_narrative":"ETF1 encodes eukaryotic release factor 1 (eRF1), a class-1 translation termination factor that recognizes all three stop codons and catalyzes peptide release at the ribosome, a role first inferred from its strong sequence homology to the yeast omnipotent suppressor SUP45 [PMID:1537561, PMID:11996793]. Reconstituted mammalian translation assays establish that eRF1 binds ribosomal subunits and pre-termination complexes, interacts with eRF3a, and stimulates its GTPase activity to drive termination; a shorter isoform 2 retains ribosome and eRF3a binding but exhibits reduced codon recognition and peptide release, UGA unipotency, and weak eRF3a GTPase stimulation, and accordingly suppresses uORF readthrough and dampens translation of long coding sequences [PMID:39063238]. The fidelity of eRF1-mediated termination is tuned by its localization: under arsenite-induced oxidative stress eRF1 is sequestered into stress granules concurrent with elevated stop-codon readthrough and reinitiation [PMID:36672194], and in C9orf72-repeat-expansion ALS/FTD neurons its nucleocytoplasmic redistribution can be exploited—co-overexpression with UPF1 shifts the cell toward NMD-dependent mRNA degradation and rescues toxicity in vivo [PMID:32059759]. Beyond termination per se, ETF1 contributes to gene-expression buffering, with its knockdown altering mRNA stability inversely to transcription rate [PMID:31116665]. ETF1 is also a small-molecule target: stereoprobes that bind purified eRF1 modulate programmed ribosomal frameshifting and suppress SARS-CoV-2 and other viral replication [PMID:40909472], and a KDM3B-ETF1 fusion protein binds and represses the LMO2 locus to activate WNT/β-catenin signaling and promote breast cancer invasion [PMID:33828234].","teleology":[{"year":1992,"claim":"Established the candidate identity of the human gene by showing it encodes a protein homologous to a known translation termination factor, framing it as the mammalian release factor.","evidence":"cDNA cloning and sequence homology comparison to yeast SUP45","pmids":["1537561","1546371"],"confidence":"Medium","gaps":["Function inferred from homology only, no biochemical termination assay","Genomic signals mapped to multiple chromosomes, functional locus not yet resolved"]},{"year":2000,"claim":"Resolved which locus carries the functional gene versus pseudogenes, placing ETF1 at 5q31 within a region deleted in myelodysplasia/AML and motivating disease relevance.","evidence":"FISH and microsatellite marker mapping; identification of processed pseudogenes","pmids":["10773672"],"confidence":"High","gaps":["Chromosomal location does not establish a causal role in the associated malignancies","No mutation or expression analysis tying ETF1 to MDS/AML phenotype"]},{"year":2003,"claim":"Characterized ETF1 as a housekeeping-type gene with constitutive yet tissue-regulated transcription, consistent with a ubiquitously required termination factor.","evidence":"Promoter mapping (Inr, Sp1/Sp3, no TATA box), footprinting, transient expression and RT-PCR","pmids":["11996793","14563555"],"confidence":"Medium","gaps":["Catalytic release-factor activity asserted from homology, not directly assayed here","Regulatory elements defined in reporters, not validated at endogenous locus"]},{"year":2011,"claim":"Showed ETF1 pre-mRNA is itself a substrate of splicing regulation, revealing a layer of post-transcriptional control over the factor.","evidence":"TDP-43 UG-repeat splicing assays with ETF1 minigene reporters","pmids":["22100394"],"confidence":"Medium","gaps":["Effect on endogenous ETF1 isoform ratios in cells not quantified","Functional consequence for termination activity not assessed"]},{"year":2019,"claim":"Connected ETF1 to gene-expression homeostasis beyond termination by demonstrating its role in buffering mRNA abundance through coupled decay and transcription.","evidence":"siRNA knockdown in HepG2 with mRNA stability and transcription-rate readouts","pmids":["31116665"],"confidence":"Medium","gaps":["Mechanistic link between termination activity and transcriptional feedback unresolved","Buffering shown for specific transcripts, generality untested"]},{"year":2020,"claim":"Linked eRF1 localization to neurodegeneration, showing C9-HRE-driven redistribution and that boosting eRF1/UPF1 redirects the cell toward NMD and mitigates toxicity.","evidence":"Fractionation-MS, iPSC neuron/postmortem imaging, eRF1/UPF1 overexpression rescue in Drosophila and zebrafish","pmids":["32059759"],"confidence":"High","gaps":["Whether endogenous eRF1 levels are limiting in disease not established","Direct contribution of termination activity versus NMD coupling to rescue not dissected"]},{"year":2023,"claim":"Demonstrated stress-dependent regulation of termination fidelity by showing eRF1 sequestration in stress granules coincides with increased readthrough.","evidence":"Immunofluorescence of eRF1 to stress granules plus readthrough and reinitiation reporters under arsenite stress","pmids":["36672194"],"confidence":"Medium","gaps":["Causal link between sequestration and readthrough is correlative","Quantitative contribution of eRF1 depletion versus other factors unresolved"]},{"year":2024,"claim":"Provided direct biochemical definition of eRF1 termination activity and showed isoform 2 is a functionally attenuated, UGA-restricted variant that reshapes readthrough and elongation.","evidence":"Reconstituted mammalian in vitro translation: ribosome/pre-termination binding, codon recognition, peptide release, eRF3a GTPase stimulation, readthrough reporters","pmids":["39063238"],"confidence":"High","gaps":["Physiological abundance and regulation of isoform 2 in tissues not established","Structural basis of UGA unipotency not resolved"]},{"year":2021,"claim":"Revealed a non-canonical oncogenic activity of an ETF1 fusion, repurposing the protein as a chromatin-targeting repressor of LMO2 that drives WNT/β-catenin-dependent invasion.","evidence":"ChIP, Western blot, Transwell invasion and xenograft assays with KDM3B-ETF1 overexpression/knockdown","pmids":["33828234"],"confidence":"Medium","gaps":["Applies to the fusion protein, not wild-type ETF1","Contribution of the ETF1 moiety versus KDM3B moiety to LMO2 targeting not dissected"]},{"year":2025,"claim":"Established eRF1 as a druggable target for antiviral intervention via small molecules that modulate programmed ribosomal frameshifting without degrading the protein.","evidence":"Phenotypic stereoprobe screen, chemical proteomics, recombinant ETF1 binding, frameshifting and viral replication assays (preprint)","pmids":["40909472"],"confidence":"Medium","gaps":["Preprint, single lab, not peer-reviewed","Binding site on eRF1 and mechanism of frameshifting modulation not defined","Selectivity over canonical termination activity not characterized"]},{"year":null,"claim":"How eRF1 catalytic engagement, subcellular sequestration, and isoform choice are coordinated to set readthrough and termination fidelity across physiological and disease states remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of human eRF1 in the termination complex in the corpus","Regulation of isoform 1 versus isoform 2 expression in vivo unknown","Mechanism connecting stress-granule sequestration to specific readthrough events undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[3,9]},{"term_id":"GO:0045182","term_label":"translation regulator activity","supporting_discovery_ids":[3,9,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[7,8]},{"term_id":"GO:0005635","term_label":"nuclear envelope","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[6,7]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[3,9]}],"complexes":["pre-termination complex / ribosome"],"partners":["ETF1 (ERF3A/GSPT1)","UPF1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P62495","full_name":"Eukaryotic peptide chain release factor subunit 1","aliases":["Protein Cl1","TB3-1"],"length_aa":437,"mass_kda":49.0,"function":"Component of the eRF1-eRF3-GTP ternary complex, a ternary complex that mediates translation termination in response to the termination codons (PubMed:10676813, PubMed:16777602, PubMed:24486019, PubMed:26245381, PubMed:27863242, PubMed:36638793, PubMed:7990965). The eRF1-eRF3-GTP complex binds to a stop codon in the ribosomal A-site (PubMed:26245381, PubMed:27863242, PubMed:36638793). ETF1/ERF1 is responsible for stop codon recognition and inducing hydrolysis of peptidyl-tRNA (PubMed:26245381, PubMed:27863242, PubMed:36638793). Following GTP hydrolysis, eRF3 (GSPT1/ERF3A or GSPT2/ERF3B) dissociates, permitting ETF1/eRF1 to accommodate fully in the A-site and mediate hydrolysis of peptidyl-tRNA (PubMed:10676813, PubMed:16777602, PubMed:26245381, PubMed:27863242). Component of the transient SURF complex which recruits UPF1 to stalled ribosomes in the context of nonsense-mediated decay (NMD) of mRNAs containing premature stop codons (PubMed:19417104). Required for SHFL-mediated translation termination which inhibits programmed ribosomal frameshifting (-1PRF) of mRNA from viruses and cellular genes (PubMed:30682371)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P62495/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/ETF1","classification":"Common Essential","n_dependent_lines":1207,"n_total_lines":1208,"dependency_fraction":0.9991721854304636},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"GSPT1","stoichiometry":10.0},{"gene":"U2SURP","stoichiometry":10.0},{"gene":"EFTUD2","stoichiometry":0.2},{"gene":"SAR1B","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ETF1","total_profiled":1310},"omim":[{"mim_id":"620928","title":"JUMONJI DOMAIN-CONTAINING PROTEIN 4; JMJD4","url":"https://www.omim.org/entry/620928"},{"mim_id":"614260","title":"CHROMOSOME 9 OPEN READING FRAME 72; C9ORF72","url":"https://www.omim.org/entry/614260"},{"mim_id":"613176","title":"SMG9 NONSENSE-MEDIATED mRNA DECAY FACTOR; SMG9","url":"https://www.omim.org/entry/613176"},{"mim_id":"613175","title":"SMG8 NONSENSE-MEDIATED mRNA DECAY FACTOR; SMG8","url":"https://www.omim.org/entry/613175"},{"mim_id":"607032","title":"SMG1 NONSENSE-MEDIATED mRNA DECAY-ASSOCIATED PI3K-RELATED KINASE; SMG1","url":"https://www.omim.org/entry/607032"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ETF1"},"hgnc":{"alias_symbol":["eRF1","TB3-1","RF1"],"prev_symbol":["SUP45L1","ERF1","ERF"]},"alphafold":{"accession":"P62495","domains":[{"cath_id":"3.30.960.10","chopping":"23-139","consensus_level":"high","plddt":89.3128,"start":23,"end":139},{"cath_id":"3.30.420.60","chopping":"145-177_203-278","consensus_level":"high","plddt":89.5228,"start":145,"end":278},{"cath_id":"3.30.1330.30","chopping":"300-424","consensus_level":"high","plddt":85.4451,"start":300,"end":424}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P62495","model_url":"https://alphafold.ebi.ac.uk/files/AF-P62495-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P62495-F1-predicted_aligned_error_v6.png","plddt_mean":85.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ETF1","jax_strain_url":"https://www.jax.org/strain/search?query=ETF1"},"sequence":{"accession":"P62495","fasta_url":"https://rest.uniprot.org/uniprotkb/P62495.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P62495/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P62495"}},"corpus_meta":[{"pmid":"12186856","id":"PMC_12186856","title":"Novel PtdIns(3)P-binding protein Etf1 functions as an effector of the Vps34 PtdIns 3-kinase in autophagy.","date":"2002","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12186856","citation_count":83,"is_preprint":false},{"pmid":"32059759","id":"PMC_32059759","title":"Nucleocytoplasmic Proteomic Analysis Uncovers eRF1 and Nonsense-Mediated Decay as Modifiers of ALS/FTD C9orf72 Toxicity.","date":"2020","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/32059759","citation_count":70,"is_preprint":false},{"pmid":"26833392","id":"PMC_26833392","title":"miR-150 regulates obesity-associated insulin resistance by controlling B cell functions.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26833392","citation_count":63,"is_preprint":false},{"pmid":"27541856","id":"PMC_27541856","title":"Ehrlichia secretes Etf-1 to induce autophagy and capture nutrients for its growth through RAB5 and class III phosphatidylinositol 3-kinase.","date":"2016","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/27541856","citation_count":61,"is_preprint":false},{"pmid":"1999460","id":"PMC_1999460","title":"Identification of a novel, N-ethylmaleimide-sensitive cytosolic factor required for vesicular transport from endosomes to the trans-Golgi network in vitro.","date":"1991","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1999460","citation_count":58,"is_preprint":false},{"pmid":"34074773","id":"PMC_34074773","title":"Iron robbery by intracellular pathogen via bacterial effector-induced ferritinophagy.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34074773","citation_count":46,"is_preprint":false},{"pmid":"17982254","id":"PMC_17982254","title":"Differential regulation of serum- and glucocorticoid-inducible kinase 1 (SGK1) splice variants based on alternative initiation of transcription.","date":"2007","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17982254","citation_count":45,"is_preprint":false},{"pmid":"27387891","id":"PMC_27387891","title":"A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patients.","date":"2016","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/27387891","citation_count":39,"is_preprint":false},{"pmid":"29536364","id":"PMC_29536364","title":"Role and Function of the Type IV Secretion System in Anaplasma and Ehrlichia Species.","date":"2017","source":"Current topics in microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29536364","citation_count":39,"is_preprint":false},{"pmid":"11673265","id":"PMC_11673265","title":"Temporal effect of human oviductal cell and its derived embryotrophic factors on mouse embryo development.","date":"2001","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/11673265","citation_count":38,"is_preprint":false},{"pmid":"1655904","id":"PMC_1655904","title":"Functional properties of guinea pig eosinophil leukotriene B4 receptor.","date":"1991","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1655904","citation_count":32,"is_preprint":false},{"pmid":"1537561","id":"PMC_1537561","title":"Identification of a human cDNA with high homology to yeast omnipotent suppressor 45.","date":"1992","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/1537561","citation_count":32,"is_preprint":false},{"pmid":"33903242","id":"PMC_33903242","title":"An intracellular nanobody targeting T4SS effector inhibits Ehrlichia infection.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33903242","citation_count":31,"is_preprint":false},{"pmid":"22100394","id":"PMC_22100394","title":"UG repeats/TDP-43 interactions near 5' splice sites exert unpredictable effects on splicing modulation.","date":"2011","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22100394","citation_count":28,"is_preprint":false},{"pmid":"19631775","id":"PMC_19631775","title":"Fibroblast growth factor 2-induced cytoplasmic asparaginyl-tRNA synthetase promotes survival of osteoblasts by regulating anti-apoptotic PI3K/Akt signaling.","date":"2009","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/19631775","citation_count":28,"is_preprint":false},{"pmid":"35155275","id":"PMC_35155275","title":"The \"Biological Weapons\" of Ehrlichia chaffeensis: Novel Molecules and Mechanisms to Subjugate Host Cells.","date":"2022","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/35155275","citation_count":25,"is_preprint":false},{"pmid":"32193339","id":"PMC_32193339","title":"Host membrane lipids are trafficked to membranes of intravacuolar bacterium Ehrlichia chaffeensis.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32193339","citation_count":25,"is_preprint":false},{"pmid":"27450446","id":"PMC_27450446","title":"Identification of Susceptible Loci and Enriched Pathways for Bipolar II Disorder Using Genome-Wide Association Studies.","date":"2016","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27450446","citation_count":23,"is_preprint":false},{"pmid":"31116665","id":"PMC_31116665","title":"mRNA levels are buffered upon knockdown of RNA decay and translation factors via adjustment of transcription rates in human HepG2 cells.","date":"2019","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/31116665","citation_count":22,"is_preprint":false},{"pmid":"11996793","id":"PMC_11996793","title":"Evaluation of ETF1/eRF1, mapping to 5q31, as a candidate myeloid tumor suppressor gene.","date":"2002","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/11996793","citation_count":19,"is_preprint":false},{"pmid":"28638803","id":"PMC_28638803","title":"Peptide Nucleic Acid Knockdown and Intra-host Cell Complementation of Ehrlichia Type IV Secretion System Effector.","date":"2017","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28638803","citation_count":19,"is_preprint":false},{"pmid":"19550121","id":"PMC_19550121","title":"Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma.","date":"2009","source":"Ai zheng = Aizheng = Chinese journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19550121","citation_count":16,"is_preprint":false},{"pmid":"22961600","id":"PMC_22961600","title":"Subdivision of molecularly-classified groups by new gene signatures in breast cancer patients.","date":"2012","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/22961600","citation_count":14,"is_preprint":false},{"pmid":"36081986","id":"PMC_36081986","title":"Identification of Four Biomarkers of Human Skin Aging by Comprehensive Single Cell Transcriptome, Transcriptome, and Proteomics.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36081986","citation_count":13,"is_preprint":false},{"pmid":"28494008","id":"PMC_28494008","title":"Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28494008","citation_count":13,"is_preprint":false},{"pmid":"29532746","id":"PMC_29532746","title":"Investigation of mechanisms of mesenchymal stem cells for treatment of diabetic nephropathy via construction of a miRNA-TF-mRNA network.","date":"2018","source":"Renal failure","url":"https://pubmed.ncbi.nlm.nih.gov/29532746","citation_count":12,"is_preprint":false},{"pmid":"36672194","id":"PMC_36672194","title":"Relocalization of Translation Termination and Ribosome Recycling Factors to Stress Granules Coincides with Elevated Stop-Codon Readthrough and Reinitiation Rates upon Oxidative Stress.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36672194","citation_count":12,"is_preprint":false},{"pmid":"33828234","id":"PMC_33828234","title":"KDM3B-ETF1 fusion gene downregulates LMO2 via the WNT/β-catenin signaling pathway, promoting metastasis of invasive ductal carcinoma.","date":"2021","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33828234","citation_count":11,"is_preprint":false},{"pmid":"33014055","id":"PMC_33014055","title":"A Novel Signature Based on mTORC1 Pathway in Hepatocellular Carcinoma.","date":"2020","source":"Journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33014055","citation_count":9,"is_preprint":false},{"pmid":"35031034","id":"PMC_35031034","title":"Differential proteomic analysis demonstrates follicle fluid participate immune reaction and protein translation in yak.","date":"2022","source":"BMC veterinary research","url":"https://pubmed.ncbi.nlm.nih.gov/35031034","citation_count":9,"is_preprint":false},{"pmid":"36874272","id":"PMC_36874272","title":"Inhibition of Ehrlichia chaffeensis infection by cell-permeable macrocyclic peptides that bind type IV secretion effector Etf-1.","date":"2023","source":"PNAS nexus","url":"https://pubmed.ncbi.nlm.nih.gov/36874272","citation_count":8,"is_preprint":false},{"pmid":"7543834","id":"PMC_7543834","title":"Cloning and identification of genes differentially expressed in metastatic and non-metastatic rat rhabdomyosarcoma cell lines.","date":"1995","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/7543834","citation_count":8,"is_preprint":false},{"pmid":"14563555","id":"PMC_14563555","title":"Promoter analysis of the human translation termination factor 1 gene.","date":"2003","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/14563555","citation_count":8,"is_preprint":false},{"pmid":"33367491","id":"PMC_33367491","title":"Identifying age-specific gene signatures of the human cerebral cortex with joint analysis of transcriptomes and functional connectomes.","date":"2021","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/33367491","citation_count":8,"is_preprint":false},{"pmid":"32469390","id":"PMC_32469390","title":"Computational analysis and verification of molecular genetic targets for glioblastoma.","date":"2020","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/32469390","citation_count":7,"is_preprint":false},{"pmid":"35310196","id":"PMC_35310196","title":"miR-195 Inhibits Proliferation and Enhances Apoptosis of OSCC Cells via Targeting TLR4.","date":"2022","source":"Journal of healthcare engineering","url":"https://pubmed.ncbi.nlm.nih.gov/35310196","citation_count":6,"is_preprint":false},{"pmid":"1546371","id":"PMC_1546371","title":"Chromosomal localization of a human cDNA containing a DIDS binding domain and demonstrating high homology to yeast omnipotent suppressor 45.","date":"1992","source":"Somatic cell and molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1546371","citation_count":6,"is_preprint":false},{"pmid":"10773672","id":"PMC_10773672","title":"Eukaryotic translation termination factor gene (ETF1/eRF1) maps at D5S500 in a commonly deleted region of chromosome 5q31 in malignant myeloid diseases.","date":"2000","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10773672","citation_count":5,"is_preprint":false},{"pmid":"34846081","id":"PMC_34846081","title":"Comprehensive analyses of microRNA and mRNA expression in colorectal serrated lesions and colorectal cancer with a microsatellite instability phenotype.","date":"2021","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34846081","citation_count":5,"is_preprint":false},{"pmid":"31245876","id":"PMC_31245876","title":"Identification of Gli1-interacting proteins during simvastatin-stimulated osteogenic differentiation of bone marrow mesenchymal stem cells.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31245876","citation_count":4,"is_preprint":false},{"pmid":"30336044","id":"PMC_30336044","title":"Large-Scale Proteomic Identification of Targets of Cellular miR-197 Downregulated by Enterovirus A71.","date":"2018","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/30336044","citation_count":4,"is_preprint":false},{"pmid":"40909472","id":"PMC_40909472","title":"Integrated phenotypic screening and chemical proteomics identifies ETF1 ligands that modulate viral translation and replication.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40909472","citation_count":2,"is_preprint":false},{"pmid":"39063238","id":"PMC_39063238","title":"Functional Activity of Isoform 2 of Human eRF1.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39063238","citation_count":2,"is_preprint":false},{"pmid":"40906190","id":"PMC_40906190","title":"Bidirectional Hypoxic Extracellular Vesicle Signaling Between Müller Glia and Retinal Pigment Epithelium Regulates Retinal Metabolism and Barrier Function.","date":"2025","source":"Biology","url":"https://pubmed.ncbi.nlm.nih.gov/40906190","citation_count":2,"is_preprint":false},{"pmid":"21426775","id":"PMC_21426775","title":"[Anti-sense miRNA-21 oligonucleotide inhibits Tb 3.1 human tongue squamous cell carcinoma growth in vitro].","date":"2011","source":"Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology","url":"https://pubmed.ncbi.nlm.nih.gov/21426775","citation_count":1,"is_preprint":false},{"pmid":"40918171","id":"PMC_40918171","title":"Neuroprotective Effects of Black Raspberry Extract Against β-Amyloid-Induced Cytotoxicity in HT-22 Cells.","date":"2025","source":"Food science & nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/40918171","citation_count":0,"is_preprint":false},{"pmid":"28317360","id":"PMC_28317360","title":"[Construction of epithelial membrane protein 1 eukaryotic expression vector and its influence on migration and invasion of human oral tongue squamous carcinoma cells].","date":"2016","source":"Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology","url":"https://pubmed.ncbi.nlm.nih.gov/28317360","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":27929,"output_tokens":3088,"usd":0.065054,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10521,"output_tokens":3479,"usd":0.06979,"stage2_stop_reason":"end_turn"},"total_usd":0.134844,"stage1_batch_id":"msgbatch_01AsKq64opiyvpDv2j3FexYQ","stage2_batch_id":"msgbatch_01XG5TnAVxejxY779cwb2uS8","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"Human TB3-1 (ETF1) encodes a 47.8-kDa protein sharing 73% amino acid similarity with yeast omnipotent suppressor 45 (SUP45), suggesting a conserved role in translation termination/stop codon recognition in mammalian cells.\",\n      \"method\": \"cDNA cloning from T84 adenocarcinoma library, open reading frame analysis, sequence homology comparison\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — structural homology to a characterized yeast translation termination factor established by sequence analysis; no in vitro functional assay performed in this paper, but independently confirmed by chromosomal mapping study\",\n      \"pmids\": [\"1537561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"TB3-1 (ETF1) genomic sequences map to human chromosomes 5, 6, 7, and X; the gene is well conserved in higher vertebrates including mammals and chicken.\",\n      \"method\": \"Human-mouse somatic cell panel analysis, Southern blot of mammalian and chicken genomic DNA\",\n      \"journal\": \"Somatic cell and molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct chromosomal localization by somatic cell panel and Southern blot, two orthogonal methods, single lab\",\n      \"pmids\": [\"1546371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The functional ETF1 gene resides on chromosome 5q31 at locus D5S500 (within the smallest commonly deleted segment in myelodysplastic syndromes/AML); three processed pseudogenes exist on chromosomes 6, 7, and X.\",\n      \"method\": \"Fluorescence in situ hybridization (FISH), microsatellite marker identification in intron 7\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — FISH-based chromosomal localization, replicated and extended by a subsequent study (PMID:11996793)\",\n      \"pmids\": [\"10773672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ETF1/eRF1 is a class-1 release factor that catalyses termination of protein synthesis at all three stop codons; the ETF1 promoter lacks a TATA box but contains an initiator element (Inr) and Sp1/Sp3 binding sites consistent with housekeeping gene regulation, with tissue-specific expression detected by RT-PCR.\",\n      \"method\": \"Primer extension, RNase protection mapping, DNase I hypersensitive site analysis, transient expression assays, in vivo/in vitro footprinting, real-time quantitative RT-PCR\",\n      \"journal\": \"Cancer genetics and cytogenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods characterizing promoter elements and transcriptional regulation; functional role as release factor stated but relies on homology; single lab\",\n      \"pmids\": [\"11996793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The ETF1 gene promoter contains a basal promoter (−210/+117) with an Inr element and Sp1/Sp3 binding sites (no TATA box), plus an upstream region with both positive and negative regulatory elements, consistent with constitutive but tissue-regulated expression.\",\n      \"method\": \"Primer extension, RNase protection, DNase I hypersensitivity, transient expression assays, in vivo and in vitro footprinting, quantitative RT-PCR in mouse tissues\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal promoter-analysis methods in one study; single lab\",\n      \"pmids\": [\"14563555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TDP-43 binding to UG-repeated sequences near the 5' splice site of ETF1 pre-mRNA can act as either an activator or a suppressor of 5' splice-site recognition, depending on splice-site strength and additional splicing regulatory sequences.\",\n      \"method\": \"Splicing assays with artificial and natural substrates; UG-repeat mutagenesis; minigene reporters for BRCA1, ETF1, and RXRG\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct experimental manipulation of UG repeats in ETF1 pre-mRNA splicing substrates; single lab, single method type\",\n      \"pmids\": [\"22100394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Knockdown of ETF1 in human HepG2 cells alters the stability of specific mRNAs, and this change in mRNA half-life is inversely associated with altered transcription rates, such that mRNA abundance is buffered—demonstrating that ETF1 participates in a gene-expression buffering mechanism linking mRNA decay to transcription.\",\n      \"method\": \"siRNA knockdown of ETF1, mRNA stability measurements, transcription rate assays\",\n      \"journal\": \"RNA biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct knockdown with both stability and transcription-rate readouts in human cells; single lab\",\n      \"pmids\": [\"31116665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"eRF1 (ETF1 protein) accumulates within nuclear envelope invaginations in C9orf72-HRE patient iPSC neurons and postmortem tissue; its cytoplasmic redistribution is driven by nucleocytoplasmic transport disruption caused by C9-HRE. Overexpression of eRF1 together with UPF1 shifts translation toward NMD-dependent mRNA degradation and ameliorates C9-HRE toxicity in vivo.\",\n      \"method\": \"Subcellular fractionation coupled with tandem mass spectrometry; iPSC neuron and postmortem tissue immunostaining; eRF1/UPF1 overexpression in Drosophila and zebrafish C9-HRE models\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — proteome-wide fractionation-MS identifies redistribution, orthogonal imaging confirms localization, in vivo rescue experiments confirm functional role; multiple methods across multiple model systems\",\n      \"pmids\": [\"32059759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Upon arsenite-induced oxidative stress, eRF1 (ETF1) relocalizes to stress granules (SGs) coinciding with a dramatic increase in stop-codon readthrough rate and elevated translation reinitiation levels, suggesting eRF1 sequestration in SGs contributes to reduced translation termination fidelity under stress.\",\n      \"method\": \"Immunofluorescence localization of eRF1 and other translation factors to SGs; stop-codon readthrough reporter assays; translation reinitiation assays on uORF-containing and bicistronic mRNAs\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct imaging of eRF1 localization to SGs plus functional readthrough assays; single lab, mechanistic link is correlative\",\n      \"pmids\": [\"36672194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ETF1 isoform 2 (33 amino acids shorter than canonical eRF1 isoform 1) retains the ability to interact with ribosomal subunits and pre-termination complexes and to interact with eRF3a, but shows decreased codon recognition and peptide release activities, exhibits UGA unipotency, and stimulates eRF3a GTPase activity significantly less than isoform 1; it suppresses stop-codon readthrough of uORFs and decreases translation efficiency of long coding sequences.\",\n      \"method\": \"Reconstituted mammalian in vitro translation system; ribosome-binding and pre-termination complex interaction assays; GTPase activity assay; stop-codon readthrough reporters; cell-free translation system\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro translation system with direct functional assays (peptide release, codon recognition, GTPase stimulation, readthrough); multiple orthogonal biochemical methods; single lab\",\n      \"pmids\": [\"39063238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Small-molecule photo-stereoprobes identified by phenotypic screening bind directly to ETF1 (eRF1) — confirmed by chemical proteomics and recombinant purified ETF1 — and modulate programmed ribosomal frameshifting essential for SARS-CoV-2 replication without causing ETF1 degradation, thereby suppressing replication of multiple viruses with non-canonical frameshifting mechanisms.\",\n      \"method\": \"Phenotypic screening of photoreactive small-molecule library; chemical proteomics (photoaffinity labeling); binding confirmation with recombinant purified ETF1; frameshifting reporter assays; viral replication assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chemical proteomics plus recombinant protein binding and functional frameshifting assays; preprint, single lab\",\n      \"pmids\": [\"40909472\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The KDM3B-ETF1 fusion gene (arising from chromosomal rearrangement) targets the LMO2 locus via chromatin immunoprecipitation-confirmed binding, reduces LMO2 expression, and activates the WNT/β-catenin signaling pathway to promote breast cancer cell invasion and metastasis.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), Western blot, cell counting kit-8, Transwell invasion assay, tumor xenograft in nude mice; KDM3B-ETF1 overexpression and knockdown\",\n      \"journal\": \"Cancer gene therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirms direct targeting of LMO2 by the fusion protein; multiple functional assays in vitro and in vivo; single lab; applies to fusion protein, not canonical ETF1 alone\",\n      \"pmids\": [\"33828234\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ETF1 encodes eukaryotic release factor 1 (eRF1), a class-1 translation termination factor that recognizes all three stop codons, induces peptide release from the ribosome, and stimulates eRF3 GTPase activity; a shorter isoform 2 retains ribosome binding and eRF3 interaction but shows reduced catalytic activity and UGA-only codon recognition; under oxidative stress eRF1 relocalizes to stress granules coinciding with increased stop-codon readthrough, and in C9orf72-ALS/FTD neurons its cytoplasmic redistribution shifts the cell toward NMD-dependent mRNA degradation; small molecules that bind eRF1 modulate programmed ribosomal frameshifting to suppress viral replication, and a KDM3B-ETF1 fusion protein represses LMO2 via WNT/β-catenin signaling to promote breast cancer invasion.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ETF1 encodes eukaryotic release factor 1 (eRF1), a class-1 translation termination factor that recognizes all three stop codons and catalyzes peptide release at the ribosome, a role first inferred from its strong sequence homology to the yeast omnipotent suppressor SUP45 [#0, #3]. Reconstituted mammalian translation assays establish that eRF1 binds ribosomal subunits and pre-termination complexes, interacts with eRF3a, and stimulates its GTPase activity to drive termination; a shorter isoform 2 retains ribosome and eRF3a binding but exhibits reduced codon recognition and peptide release, UGA unipotency, and weak eRF3a GTPase stimulation, and accordingly suppresses uORF readthrough and dampens translation of long coding sequences [#9]. The fidelity of eRF1-mediated termination is tuned by its localization: under arsenite-induced oxidative stress eRF1 is sequestered into stress granules concurrent with elevated stop-codon readthrough and reinitiation [#8], and in C9orf72-repeat-expansion ALS/FTD neurons its nucleocytoplasmic redistribution can be exploited—co-overexpression with UPF1 shifts the cell toward NMD-dependent mRNA degradation and rescues toxicity in vivo [#7]. Beyond termination per se, ETF1 contributes to gene-expression buffering, with its knockdown altering mRNA stability inversely to transcription rate [#6]. ETF1 is also a small-molecule target: stereoprobes that bind purified eRF1 modulate programmed ribosomal frameshifting and suppress SARS-CoV-2 and other viral replication [#10], and a KDM3B-ETF1 fusion protein binds and represses the LMO2 locus to activate WNT/\\u03b2-catenin signaling and promote breast cancer invasion [#11].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Established the candidate identity of the human gene by showing it encodes a protein homologous to a known translation termination factor, framing it as the mammalian release factor.\",\n      \"evidence\": \"cDNA cloning and sequence homology comparison to yeast SUP45\",\n      \"pmids\": [\"1537561\", \"1546371\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Function inferred from homology only, no biochemical termination assay\", \"Genomic signals mapped to multiple chromosomes, functional locus not yet resolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Resolved which locus carries the functional gene versus pseudogenes, placing ETF1 at 5q31 within a region deleted in myelodysplasia/AML and motivating disease relevance.\",\n      \"evidence\": \"FISH and microsatellite marker mapping; identification of processed pseudogenes\",\n      \"pmids\": [\"10773672\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chromosomal location does not establish a causal role in the associated malignancies\", \"No mutation or expression analysis tying ETF1 to MDS/AML phenotype\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Characterized ETF1 as a housekeeping-type gene with constitutive yet tissue-regulated transcription, consistent with a ubiquitously required termination factor.\",\n      \"evidence\": \"Promoter mapping (Inr, Sp1/Sp3, no TATA box), footprinting, transient expression and RT-PCR\",\n      \"pmids\": [\"11996793\", \"14563555\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Catalytic release-factor activity asserted from homology, not directly assayed here\", \"Regulatory elements defined in reporters, not validated at endogenous locus\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed ETF1 pre-mRNA is itself a substrate of splicing regulation, revealing a layer of post-transcriptional control over the factor.\",\n      \"evidence\": \"TDP-43 UG-repeat splicing assays with ETF1 minigene reporters\",\n      \"pmids\": [\"22100394\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Effect on endogenous ETF1 isoform ratios in cells not quantified\", \"Functional consequence for termination activity not assessed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Connected ETF1 to gene-expression homeostasis beyond termination by demonstrating its role in buffering mRNA abundance through coupled decay and transcription.\",\n      \"evidence\": \"siRNA knockdown in HepG2 with mRNA stability and transcription-rate readouts\",\n      \"pmids\": [\"31116665\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic link between termination activity and transcriptional feedback unresolved\", \"Buffering shown for specific transcripts, generality untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Linked eRF1 localization to neurodegeneration, showing C9-HRE-driven redistribution and that boosting eRF1/UPF1 redirects the cell toward NMD and mitigates toxicity.\",\n      \"evidence\": \"Fractionation-MS, iPSC neuron/postmortem imaging, eRF1/UPF1 overexpression rescue in Drosophila and zebrafish\",\n      \"pmids\": [\"32059759\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether endogenous eRF1 levels are limiting in disease not established\", \"Direct contribution of termination activity versus NMD coupling to rescue not dissected\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrated stress-dependent regulation of termination fidelity by showing eRF1 sequestration in stress granules coincides with increased readthrough.\",\n      \"evidence\": \"Immunofluorescence of eRF1 to stress granules plus readthrough and reinitiation reporters under arsenite stress\",\n      \"pmids\": [\"36672194\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal link between sequestration and readthrough is correlative\", \"Quantitative contribution of eRF1 depletion versus other factors unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Provided direct biochemical definition of eRF1 termination activity and showed isoform 2 is a functionally attenuated, UGA-restricted variant that reshapes readthrough and elongation.\",\n      \"evidence\": \"Reconstituted mammalian in vitro translation: ribosome/pre-termination binding, codon recognition, peptide release, eRF3a GTPase stimulation, readthrough reporters\",\n      \"pmids\": [\"39063238\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological abundance and regulation of isoform 2 in tissues not established\", \"Structural basis of UGA unipotency not resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Revealed a non-canonical oncogenic activity of an ETF1 fusion, repurposing the protein as a chromatin-targeting repressor of LMO2 that drives WNT/\\u03b2-catenin-dependent invasion.\",\n      \"evidence\": \"ChIP, Western blot, Transwell invasion and xenograft assays with KDM3B-ETF1 overexpression/knockdown\",\n      \"pmids\": [\"33828234\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Applies to the fusion protein, not wild-type ETF1\", \"Contribution of the ETF1 moiety versus KDM3B moiety to LMO2 targeting not dissected\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Established eRF1 as a druggable target for antiviral intervention via small molecules that modulate programmed ribosomal frameshifting without degrading the protein.\",\n      \"evidence\": \"Phenotypic stereoprobe screen, chemical proteomics, recombinant ETF1 binding, frameshifting and viral replication assays (preprint)\",\n      \"pmids\": [\"40909472\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, single lab, not peer-reviewed\", \"Binding site on eRF1 and mechanism of frameshifting modulation not defined\", \"Selectivity over canonical termination activity not characterized\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How eRF1 catalytic engagement, subcellular sequestration, and isoform choice are coordinated to set readthrough and termination fidelity across physiological and disease states remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of human eRF1 in the termination complex in the corpus\", \"Regulation of isoform 1 versus isoform 2 expression in vivo unknown\", \"Mechanism connecting stress-granule sequestration to specific readthrough events undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [3, 9]},\n      {\"term_id\": \"GO:0045182\", \"supporting_discovery_ids\": [3, 9, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [7, 8]},\n      {\"term_id\": \"GO:0005635\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-72764\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [6, 7]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [3, 9]}\n    ],\n    \"complexes\": [\"pre-termination complex / ribosome\"],\n    \"partners\": [\"ETF1 (eRF3a/GSPT1)\", \"UPF1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":5,"faith_total":5,"faith_pct":100.0}}